Commonwealth Equity Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Sell |
63,227
-13,135
| -17% | -$16.2K | ﹤0.01% | 4101 |
|
|
2025
Q1 | $90K | Sell |
76,362
-35
| -0% | -$41 | ﹤0.01% | 4007 |
|
|
2024
Q4 | $140K | Sell |
76,397
-14,924
| -16% | -$27.3K | ﹤0.01% | 3848 |
|
|
2024
Q3 | $155K | Buy |
91,321
+78,531
| +614% | +$133K | ﹤0.01% | 3785 |
|
|
2024
Q2 | $18K | Sell |
12,790
-1,080
| -8% | -$1.52K | ﹤0.01% | 3977 |
|
|
2024
Q1 | $52K | Sell |
13,870
-1,589
| -10% | -$5.96K | ﹤0.01% | 3886 |
|
|
2023
Q4 | $152K | Sell |
15,459
-454
| -3% | -$4.46K | ﹤0.01% | 3598 |
|
|
2023
Q3 | $133K | Sell |
15,913
-667
| -4% | -$5.58K | ﹤0.01% | 3510 |
|
|
2023
Q2 | $221K | Hold |
16,580
| – | – | ﹤0.01% | 3317 |
|
|
2023
Q1 | $192 | Sell |
16,580
-185
| -1% | -$2 | ﹤0.01% | 3332 |
|
|
2022
Q4 | $137K | Sell |
16,765
-19,203
| -53% | -$157K | ﹤0.01% | 3349 |
|
|
2022
Q3 | $208K | Sell |
35,968
-6,040
| -14% | -$34.9K | ﹤0.01% | 3136 |
|
|
2022
Q2 | $185K | Sell |
42,008
-5,828
| -12% | -$25.7K | ﹤0.01% | 3228 |
|
|
2022
Q1 | $435K | Sell |
47,836
-2,105
| -4% | -$19.1K | ﹤0.01% | 2635 |
|
|
2021
Q4 | $1.02M | Buy |
49,941
+29,338
| +142% | +$600K | ﹤0.01% | 1971 |
|
|
2021
Q3 | $526K | Buy |
20,603
+3,721
| +22% | +$95K | ﹤0.01% | 2434 |
|
|
2021
Q2 | $590K | Buy |
16,882
+788
| +5% | +$27.5K | ﹤0.01% | 2342 |
|
|
2021
Q1 | $536K | Buy |
16,094
+5,526
| +52% | +$184K | ﹤0.01% | 2278 |
|
|
2020
Q4 | $274K | Buy |
+10,568
| New | +$274K | ﹤0.01% | 2657 |
|